Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Jaguar Health Inc JAGX

Healthcare
Jaguar Health, Inc. is a commercial-stage pharmaceuticals company. The Company is focused on developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for people and animals with gastrointestinal distress. It operates through two segments: human health and animal health. The animal health segment is focused on developing and commercializing... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:JAGX)

Jaguar Health Presenting December 3rd at NobleCon20 and December 5th at the Emerging Growth Conference

Accesswire 4 days ago

Jaguar Health Seeking Partner to Develop and Commercialize NP300 Second-Generation Antisecretory Prescription Drug Candidate for Treatment of General Diarrhea in Dogs

Accesswire 7 days ago

Jaguar Health Family Company Napo Therapeutics Named "Best Pharmaceuticals Innovator of the Year - Europe"

Accesswire 10 days ago

Jaguar Health Reports Third Quarter 2024 Financial Results

Accesswire November 13, 2024

Jaguar Health to Hold Investor Webcast Wednesday, November 13th at 8:30 AM Eastern Regarding Q3 2024 Financials & Corporate Updates

Accesswire November 11, 2024

FDA Approves Renewal of Canalevia-CA1, Jaguar Health's Drug for Chemotherapy-Induced Diarrhea in Dogs

Accesswire November 6, 2024

Abstract Describing Significant Results of Crofelemer for Cancer Therapy-Related Diarrhea in Breast Cancer Patients Accepted for Presentation at San Antonio Breast Cancer Symposium (SABCS)

Accesswire November 4, 2024

Significant Positive Results with Jaguar Health's Crofelemer for Chronic Refractory Diarrhea in IBS-D, Presented at American College of Gastroenterology Annual Meeting

Accesswire October 29, 2024

Jaguar Health Launches FDA-Approved Oral Mucositis Prescription Product Gelclair in the U.S.

Accesswire October 16, 2024
View More News ››

Opinion & Analysis (NDAQ:JAGX)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:JAGX)

Jaguar Health Seeking Partner to Develop and Commercialize N

NEWS: $JAGX Jaguar Health Seeking Partner to Develop and Commercialize NP300 Second-Generation Antisecretory Prescription Drug Candidate...
whytestocks - 6 days ago

Key Collaborator of Jaguar Health Joint Venture Magdalena Bi

Breaking News: $JAGX Key Collaborator of Jaguar Health Joint Venture Magdalena Biosciences Receives Prestigious Alzheimer's...
whytestocks - August 20, 2024

Jaguar Health, Inc. (NASDAQ:JAGX) &#8211; Diversifying into

http://beyondspx.com/2024/07/31/jaguar-health-inc-nasdaqjagx-diversifying-into-cancer-supportive-care-with-promising-rare-disease...
MikeTester - August 2, 2024

Issuance of New European & Australian Patents Bolster IP Pro

JUST IN: $JAGX Issuance of New European & Australian Patents Bolster IP Protection for Jaguar Health in the Treatment of Short Bowel...
whytestocks - July 8, 2024

Jaguar Health Reports Approval of All Proposals at June 2024

BREAKING NEWS: $JAGX Jaguar Health Reports Approval of All Proposals at June 2024 Annual Meeting of StockholdersJaguar to report pivotal...
whytestocks - June 21, 2024

Jaguar Health Announces Submission of Clinical Trial Applica

Breaking News: $JAGX Jaguar Health Announces Submission of Clinical Trial Applications for Crofelemer for the Rare Disease Indications...
whytestocks - May 9, 2024
View more Bullboard ››

JZR Gold Inc.

JZR Gold Inc.

JZR Gold Inc. is a Canada-based junior mining resource company. The Company is engaged in the business of the exploration and ...
View More »